Dalotuzumab (Anti-IGF1R / CD221)

Dalotuzumab (Anti-IGF1R / CD221) is a recombinant humanized monoclonal antibody directed against the insulin-like growth factor 1 receptor (IGF1R) with potential antineoplastic activity. MW : 146.78 KD.
Supplier Selleck Chemicals
Product # A2815
Sku # A2815-1mg*25
Pricing 1mg*25, $2970.00
Feedback